TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
-5.54%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.67B
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$118M |
| 2 |
Invesco QQQ Trust
QQQ
|
$111M |
| 3 |
Broadridge
BR
|
$95.1M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$93.3M |
| 5 |
Motorola Solutions
MSI
|
$90M |
Top Sells
| 1 |
Atlassian
TEAM
|
$332M |
| 2 |
NVIDIA
NVDA
|
$207M |
| 3 |
iShares China Large-Cap ETF
FXI
|
$164M |
| 4 |
Cisco
CSCO
|
$126M |
| 5 |
TSMC
TSM
|
$125M |
Sector Composition
| 1 | Financials | 19.96% |
| 2 | Technology | 17.35% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Dutch Bros
BROS
$8.38B
| $470K | ﹤0.01% |
14,488
-8,800
| -38% | -$285K |
|
1302
Lennox International
LII
$20.3B
| $468K | ﹤0.01% |
2,104
| – | – |
|
1303
Rapid Micro Biosystems
RPID
$120M
| $467K | ﹤0.01% |
133,814
| – | – |
|
1304
Arrow Electronics
ARW
$6.57B
| $466K | ﹤0.01% |
5,004
-100
| -2% | -$9.31K |
|
1305
Rocket Pharmaceuticals
RCKT
$354M
| $465K | ﹤0.01% |
33,152
-33,031
| -50% | -$463K |
|
1306
Resources Connection
RGP
$167M
| $463K | ﹤0.01% |
25,900
+11,500
| +80% | +$206K |
|
|
VERV
1307
DELISTED
Verve Therapeutics
VERV
| $463K | ﹤0.01% |
+13,542
| New | +$463K |
|
1308
Futu Holdings
FUTU
$26.1B
| $462K | ﹤0.01% |
12,684
-316
| -2% | -$11.5K |
|
1309
Orchestra BioMed
OBIO
$148M
| $459K | ﹤0.01% |
46,339
| – | – |
|
|
CNR
1310
Core Natural Resources, Inc.
CNR
$3.89B
| $457K | ﹤0.01% |
7,000
+1,100
| +19% | +$71.8K |
|
1311
Nkarta
NKTX
$161M
| $452K | ﹤0.01% |
35,784
| – | – |
|
1312
Relmada Therapeutics
RLMD
$54.8M
| $452K | ﹤0.01% |
12,500
+500
| +4% | +$18.1K |
|
1313
Par Pacific Holdings
PARR
$1.72B
| $448K | ﹤0.01% |
+28,200
| New | +$448K |
|
1314
Pennant Group
PNTG
$840M
| $448K | ﹤0.01% |
41,636
| – | – |
|
|
BLSA
1315
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $443K | ﹤0.01% |
44,047
| – | – |
|
1316
Vital Energy
VTLE
$635M
| $442K | ﹤0.01% |
+7,000
| New | +$442K |
|
1317
Erie Indemnity
ERIE
$17.5B
| $441K | ﹤0.01% |
2,005
+110
| +6% | +$24.2K |
|
|
OBE
1318
Obsidian Energy
OBE
$392M
| $439K | ﹤0.01% |
61,000
-7,663
| -11% | -$55.1K |
|
1319
Alpha and Omega Semiconductor
AOSL
$839M
| $436K | ﹤0.01% |
+13,600
| New | +$436K |
|
1320
Dynatrace
DT
$15.1B
| $435K | ﹤0.01% |
12,579
-400
| -3% | -$13.8K |
|
1321
Vale
VALE
$44.4B
| $433K | ﹤0.01% |
34,188
-955
| -3% | -$12.1K |
|
1322
Kodiak Sciences
KOD
$556M
| $425K | ﹤0.01% |
55,986
+100
| +0.2% | +$759 |
|
|
SWTX
1323
DELISTED
SpringWorks Therapeutics
SWTX
| $424K | ﹤0.01% |
15,616
| – | – |
|
1324
HEICO
HEI
$44.8B
| $417K | ﹤0.01% |
2,904
+70
| +2% | +$10.1K |
|
1325
C4 Therapeutics
CCCC
$194M
| $414K | ﹤0.01% |
48,453
-6,700
| -12% | -$57.2K |
|